TUESDAY, Aug. 20, 2024 -- Tirzepatide, the blockbuster GLP-1 medicine known as Mounjaro for diabetes and Zepbound for weight loss, cut the odds that...

Tirzepatide, a medication known under the brand names Mounjaro for diabetes and Zepbound for weight loss, has shown remarkable results in reducing the...

WEDNESDAY, Aug. 7, 2024 (HealthDay news) -- Medicare and Medicaid patients are less likely to get cutting-edge weight-loss drugs than people with...

Many patients are eager to discontinue Wegovy or Zepbound when their weight loss plateaus. But doctors say it’s difficult to go cold turkey.

Researchers at the University of Liverpool have discovered that the weight-loss drug tirzepatide could significantly reduce the risk of developing...

American reality TV star, Kylie Jenner has denied taking Ozempic to lose weight after having her two kids. In a recent interview with British Vogue,...

Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion...

NEW YORK, Aug. 19 (Xinhua) -- Ozempic and other GLP-1 drugs were supposed to revolutionize the battle against obesity, but evidence showed big...

A recent study from researchers at UT Southwestern has shed light on an unexpected benefit of a commonly prescribed weight-loss drug called...

Tirzepatide may reduce hospitalizations, improve symptoms, and decrease death risks in heart failure patients, offering new hope for those with...